Becton, Dickinson and Company (0R19.L)
USD 227.72
(1.16%)
USD 227.72
(1.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 52.78 Billion USD | -0.29% |
| 2022 | 52.93 Billion USD | -1.73% |
| 2021 | 53.86 Billion USD | -0.27% |
| 2020 | 54.01 Billion USD | 4.34% |
| 2019 | 51.76 Billion USD | -3.97% |
| 2018 | 53.9 Billion USD | 42.85% |
| 2017 | 37.73 Billion USD | 47.48% |
| 2016 | 25.58 Billion USD | -3.37% |
| 2015 | 26.47 Billion USD | 112.73% |
| 2014 | 12.44 Billion USD | 2.45% |
| 2013 | 12.14 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 52.27 Billion USD | -0.96% |
| 2024 Q3 | 55.58 Billion USD | 2.63% |
| 2024 Q2 | 54.15 Billion USD | 3.6% |
| 2023 Q1 | 53.12 Billion USD | 0.37% |
| 2023 Q4 | 52.78 Billion USD | -0.45% |
| 2023 FY | 52.78 Billion USD | -0.29% |
| 2023 Q3 | 53.01 Billion USD | -2.53% |
| 2023 Q2 | 54.39 Billion USD | 2.38% |
| 2022 FY | 52.93 Billion USD | -1.73% |
| 2022 Q3 | 53.19 Billion USD | -2.9% |
| 2022 Q4 | 52.93 Billion USD | -0.5% |
| 2022 Q2 | 54.78 Billion USD | 2.67% |
| 2022 Q1 | 53.36 Billion USD | -0.93% |
| 2021 FY | 53.86 Billion USD | -0.27% |
| 2021 Q3 | 54.33 Billion USD | -1.07% |
| 2021 Q1 | 54.74 Billion USD | 1.36% |
| 2021 Q2 | 54.92 Billion USD | 0.32% |
| 2021 Q4 | 53.86 Billion USD | -0.86% |
| 2020 FY | 54.01 Billion USD | 4.34% |
| 2020 Q4 | 54.01 Billion USD | 0.1% |
| 2020 Q2 | 53.51 Billion USD | 3.01% |
| 2020 Q3 | 53.95 Billion USD | 0.83% |
| 2020 Q1 | 51.95 Billion USD | 0.36% |
| 2019 FY | 51.76 Billion USD | -3.97% |
| 2019 Q4 | 51.76 Billion USD | -0.9% |
| 2019 Q2 | 52.59 Billion USD | -0.63% |
| 2019 Q3 | 52.23 Billion USD | -0.69% |
| 2019 Q1 | 52.93 Billion USD | -1.8% |
| 2018 FY | 53.9 Billion USD | 42.85% |
| 2018 Q4 | 53.9 Billion USD | -0.14% |
| 2018 Q3 | 53.97 Billion USD | -1.09% |
| 2018 Q2 | 54.57 Billion USD | -1.43% |
| 2018 Q1 | 55.36 Billion USD | 46.72% |
| 2017 Q1 | 24.31 Billion USD | -4.96% |
| 2017 Q2 | 24.12 Billion USD | -0.81% |
| 2017 Q3 | 37.16 Billion USD | 54.08% |
| 2017 Q4 | 37.73 Billion USD | 1.53% |
| 2017 FY | 37.73 Billion USD | 47.48% |
| 2016 Q1 | 26.04 Billion USD | -1.63% |
| 2016 FY | 25.58 Billion USD | -3.37% |
| 2016 Q4 | 25.58 Billion USD | -1.65% |
| 2016 Q3 | 26.01 Billion USD | -0.84% |
| 2016 Q2 | 26.23 Billion USD | 0.73% |
| 2015 Q2 | 28.29 Billion USD | 52.91% |
| 2015 Q1 | 18.5 Billion USD | 48.65% |
| 2015 Q3 | 27.07 Billion USD | -4.29% |
| 2015 Q4 | 26.47 Billion USD | -2.22% |
| 2015 FY | 26.47 Billion USD | 112.73% |
| 2014 Q1 | 12.03 Billion USD | -0.94% |
| 2014 FY | 12.44 Billion USD | 2.45% |
| 2014 Q2 | 12.25 Billion USD | 1.79% |
| 2014 Q3 | 12.37 Billion USD | 1.01% |
| 2014 Q4 | 12.44 Billion USD | 0.59% |
| 2013 Q2 | 11.62 Billion USD | 0.0% |
| 2013 Q3 | 11.58 Billion USD | -0.37% |
| 2013 Q4 | 12.14 Billion USD | 4.85% |
| 2013 Q1 | 11.62 Billion USD | 0.0% |
| 2013 FY | 12.14 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -14123.156% |
| Accuray Incorporated | 468.62 Million USD | -11162.689% |
| Align Technology, Inc. | 6.08 Billion USD | -767.539% |
| Elevance Health Inc. | 108.92 Billion USD | 51.546% |
| AxoGen, Inc. | 196.82 Million USD | -26715.427% |
| Boston Scientific Corporation | 35.13 Billion USD | -50.216% |
| CVS Health Corporation | 249.72 Billion USD | 78.865% |
| Cardinal Health, Inc. | 45.12 Billion USD | -16.974% |
| Centene Corporation | 84.64 Billion USD | 37.643% |
| DaVita Inc. | 17.61 Billion USD | -199.555% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 6.104% |
| Hologic, Inc. | 9.15 Billion USD | -476.453% |
| Humana Inc. | 47.06 Billion USD | -12.143% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -1519.056% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -215.574% |
| Masimo Corporation | 3.04 Billion USD | -1635.328% |
| McKesson Corporation | 67.44 Billion USD | 21.741% |
| Patterson Companies, Inc. | 2.96 Billion USD | -1677.666% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -276.409% |
| ResMed Inc. | 6.87 Billion USD | -668.0% |
| Henry Schein, Inc. | 10.57 Billion USD | -399.196% |
| Teladoc Health, Inc. | 4.39 Billion USD | -1101.629% |
| Universal Health Services, Inc. | 14.35 Billion USD | -267.629% |
| Veeva Systems Inc. | 5.91 Billion USD | -792.924% |
| Baxter International Inc. | 28.27 Billion USD | -86.66% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -241.806% |
| Danaher Corporation | 84.48 Billion USD | 37.53% |
| Stryker Corporation | 39.91 Billion USD | -32.241% |
| Medtronic plc | 89.98 Billion USD | 41.343% |